[Efficacy of setegis administration after transvesical adenomectomy].

We studied efficacy ofsetegis in different doses for therapy of lower urinary tract symptoms in patients after transvesical adenomectomy (TVAE). The analysis of case histories of 41 patients after open TVPE for prostatic adenoma has shown that setegis (terazosin) is effective in therapy of urinary bladder overactivity which is present in the majority of patients after TVAE. Compared to the controls, terazosin-treated patients improved urination more noticeably. Thus, alpha-adrenoblocker segetis is effective and safe in therapy of imperative voiding disorders with symptoms of urgent incontinence in patients after TVAE. Use of this drug can significantly contribute to successful postoperative rehabilitation of postadenomectomy patients. Setegis can be recommended for wide clinical practice.
AuthorsL M Gorilovskiĭ, M B Zingerenko, D A Lakhno
JournalUrologii︠a︡ (Moscow, Russia : 1999) (Urologiia) 2007 Nov-Dec Issue 6 Pg. 61, 63-5 ISSN: 1728-2985 [Print] Russia (Federation)
PMID18649663 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Adrenergic alpha-Antagonists
  • Terazosin
  • Prazosin
  • Adrenergic alpha-Antagonists (administration & dosage)
  • Aged
  • Humans
  • Male
  • Middle Aged
  • Prazosin (administration & dosage, analogs & derivatives)
  • Prostatic Hyperplasia (complications, rehabilitation, surgery)
  • Urination (drug effects)
  • Urination Disorders (drug therapy, etiology)
  • Urologic Surgical Procedures, Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: